We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Teladoc to Provide Diagnostic Service Via Analyte Health
Read MoreHide Full Article
In an effort to provide enhanced services to its members, Teladoc Inc. (TDOC - Free Report) , the first and the largest telehealth company in U.S., has entered into a partnership with Analyte Health, Inc.
The partnership also reflects the company’s efforts to grow inorganically. In recent years, the company completed four acquisitions – Stat Health Services Inc, Compile, Inc. “BetterHelp”, AmeriDoc and Consult A Doctor. These purchases have expanded its distribution capabilities and broadened its service offerings. The company is also waiting to close the already announced deal to acquire HealthiestYou, which is expected to give it greater access to the market of small- and medium-sized employers, a segment it sees as underserved.
These acquisitions have also resulted in top-line growth which is also reflected in the company’s share price movement which is better than the Zacks categorized Medical Services industry. In 2016, the company lost 8.13%, which is lower than the sector’s loss of 13.3% during the same time frame. The share price decline was due to investors' weariness over net losses registered by the company. Yet, the stock performed better than the sector. This throws hints of optimism over the stock’s ability to turn to profits very soon.
Coming back, as a result of this partnership, Teladoc will now be able to provide lab diagnostics services through its telehealth platform.
The new service will enable physicians in the Teladoc network, to order lab test required to confirm diagnoses that too with just a click of a button. The process will involve directing members to a convenient specimen collection location. The lab results will be ready within three days. Going ahead, the company plans to speed up these services to produce results on same-day, on-demand mobile experiences.
Apart from providing diagnostic services, Analyte Health will also provide other allied services such as managing logistics like technological infrastructure, billing and customer support.
Quintiles beat expectations in three out of the last four quarters, with an average beat of 2.57%.
INC Research Holdings beat expectations in three out of the last four quarters, with an average beat of 8.21%.
PRA Health beat expectations in three out of the last four quarters, with an average beat of 7.48%.
Zacks' Top 10 Stocks for 2017
In addition to the stocks discussed above, would you like to know about our 10 finest tickers for the entirety of 2017?
Who wouldn't? These 10 are painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. They are our primary picks to buy and hold. Be among the very first to see them >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Teladoc to Provide Diagnostic Service Via Analyte Health
In an effort to provide enhanced services to its members, Teladoc Inc. (TDOC - Free Report) , the first and the largest telehealth company in U.S., has entered into a partnership with Analyte Health, Inc.
The partnership also reflects the company’s efforts to grow inorganically. In recent years, the company completed four acquisitions – Stat Health Services Inc, Compile, Inc. “BetterHelp”, AmeriDoc and Consult A Doctor. These purchases have expanded its distribution capabilities and broadened its service offerings. The company is also waiting to close the already announced deal to acquire HealthiestYou, which is expected to give it greater access to the market of small- and medium-sized employers, a segment it sees as underserved.
These acquisitions have also resulted in top-line growth which is also reflected in the company’s share price movement which is better than the Zacks categorized Medical Services industry. In 2016, the company lost 8.13%, which is lower than the sector’s loss of 13.3% during the same time frame. The share price decline was due to investors' weariness over net losses registered by the company. Yet, the stock performed better than the sector. This throws hints of optimism over the stock’s ability to turn to profits very soon.
Coming back, as a result of this partnership, Teladoc will now be able to provide lab diagnostics services through its telehealth platform.
The new service will enable physicians in the Teladoc network, to order lab test required to confirm diagnoses that too with just a click of a button. The process will involve directing members to a convenient specimen collection location. The lab results will be ready within three days. Going ahead, the company plans to speed up these services to produce results on same-day, on-demand mobile experiences.
Apart from providing diagnostic services, Analyte Health will also provide other allied services such as managing logistics like technological infrastructure, billing and customer support.
Teladoc carries a Zacks Rank #2 (Buy). Some other stocks carrying the same rank in the same space are Quintiles IMS Holdings, Inc. , INC Research Holdings, Inc. (INCR - Free Report) and PRA Health Sciences, Inc. . You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Quintiles beat expectations in three out of the last four quarters, with an average beat of 2.57%.
INC Research Holdings beat expectations in three out of the last four quarters, with an average beat of 8.21%.
PRA Health beat expectations in three out of the last four quarters, with an average beat of 7.48%.
Zacks' Top 10 Stocks for 2017
In addition to the stocks discussed above, would you like to know about our 10 finest tickers for the entirety of 2017?
Who wouldn't? These 10 are painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. They are our primary picks to buy and hold. Be among the very first to see them >>